SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001650664-24-000070
Filing Date
2024-06-03
Accepted
2024-06-03 17:13:53
Documents
1
Period of Report
2024-05-30

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1717449223.html 4  
1 FORM 4 wk-form4_1717449223.xml 4 3836
  Complete submission text file 0001650664-24-000070.txt   5265
Mailing Address 11 HURLEY ST. CAMBRIDGE MA 02141
Business Address 11 HURLEY ST. CAMBRIDGE MA 02141 617-401-9000
Editas Medicine, Inc. (Issuer) CIK: 0001650664 (see all company filings)

IRS No.: 464097528 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O EDITAS MEDICINE, INC. 1 MAIN STREET CAMBRIDGE MA 02142
Business Address
Chatterjee Meeta (Reporting) CIK: 0001835388 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37687 | Film No.: 241014859